LATEST HEALTH NEWS
E1912, a phase 3 trial, showed ibrutinib plus rituximab combination as a new treatment option for untreated patients (aged 70 or younger) with chronic lymphocytic leukemia.
from Medindia Health News https://ift.tt/2ycaVSo
No comments
Thanks for comment via will connect you within 24 hours.